Royal Bank Of Canada Gilead Sciences, Inc. Put Options Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.5 Million - $2.16 Million	24,100 Added 2677.78%	25,000 $2.15 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $6.93 Million - $7.8 Million	-120,000 Reduced 99.26%	900 $56,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $8.5 Million - $10.6 Million	-146,700 Reduced 54.82%	120,900 $7.19 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $7.79 Million - $8.84 Million	-120,000 Reduced 30.96%	267,600 $19.4 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $9.65 Million - $10.4 Million	142,600 Added 58.2%	387,600 $27.1 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $15.6 Million - $17 Million	245,000 New	245,000 $16.9 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.